Comments on: RayzeBio, Neumora Perk Up the IPO Market, Raising $561M for Clinical Trials

Comments on: RayzeBio, Neumora Perk Up the IPO Market, Raising $561M for Clinical Trials https://medcitynews.com/2023/09/biotech-ipo-rayzebio-cancer-neumora-depression-clinical-trials/ Healthcare technology news, life science current events Wed, 27 Sep 2023 18:22:48 +0000 hourly 1 https://wordpress.org/?v=6.3.1